TY - JOUR
T1 - At What Age Should We Stop Colorectal Cancer Screening? When Is Enough, Enough?
AU - Lieberman, David
N1 - Publisher Copyright:
©2023 American Association for Cancer Research.
PY - 2023/1/9
Y1 - 2023/1/9
N2 - There is strong evidence that colorectal cancer screening can reduce both colorectal cancer incidence and mortality. Guidelines recommend screening for individuals age 45 to 75 years, but are less certain about the benefits after age 75 years. Dalmat and colleagues provide evidence that individuals with a prior negative colonoscopy 10 years or more prior to reaching age 76 to 85 years, had a low risk of colorectal cancer, and would be less likely to benefit from further screening. It is important to note that this study population did not include individuals with a family history of colon cancer or a personal history of having high-risk adenomas. These data suggest that a negative colonoscopy can be an effective risk-stratification tool when discussing further screening with elderly patients. See related article by Dalmat et al., p. 37.
AB - There is strong evidence that colorectal cancer screening can reduce both colorectal cancer incidence and mortality. Guidelines recommend screening for individuals age 45 to 75 years, but are less certain about the benefits after age 75 years. Dalmat and colleagues provide evidence that individuals with a prior negative colonoscopy 10 years or more prior to reaching age 76 to 85 years, had a low risk of colorectal cancer, and would be less likely to benefit from further screening. It is important to note that this study population did not include individuals with a family history of colon cancer or a personal history of having high-risk adenomas. These data suggest that a negative colonoscopy can be an effective risk-stratification tool when discussing further screening with elderly patients. See related article by Dalmat et al., p. 37.
UR - http://www.scopus.com/inward/record.url?scp=85145971676&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145971676&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-22-1006
DO - 10.1158/1055-9965.EPI-22-1006
M3 - Editorial
C2 - 36620899
AN - SCOPUS:85145971676
SN - 1055-9965
VL - 32
SP - 6
EP - 8
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 1
ER -